Search Results

Oliver Hartley Oliver Hartley is VP for Drug Discovery at Orion Biotechnology . He is the inventor of OB-002 as well as the key technology underlying Orion’s discovery platform. Oliver Hartley on the web LinkedIn Orion Biotechnology Dr. GPCR Ecosystem Enjoying the Dr.

oncology research led me to pursue a BSc in Biology & Economics from Carleton University, and an MSc in Biotechnology In my role at Orion Biotechnology, I work at the intersection of science and business, which includes To that end, I'm grateful to be working alongside the very talented team at Orion who translate important

Timo De Groof studied Biochemistry and Biotechnology at the University of Ghent where he graduated in During his master's studies, he specialized in Biomedical Biotechnology and Structural Biology/Biochemistry

following three years on the editorial teams of Nature Structural and Molecular Biology and Nature Biotechnology

Last summer, Julia worked at as the first-ever summer intern at Septerna, the GPCR-based biotechnology

She received her undergraduate degree in Biotechnology from KIIT University in India.

Kathryn E Livingston is currently a Product Manager at Gator Bio , a biotechnology company providing

of Heptares Therapeutics , now called Sosei Heptares , a GPCR-focused drug discovery and development biotechnology

Her work is currently funded by Biotechnology and Biological Sciences Research Council (BBSRC), Diabetes

Andrew is translating fundamental findings to commercial products is Keltic Pharma Therapeutics Ltd , a biotechnology

Sexton is also a co-founder of the San Francisco-based biotechnology company Septerna Inc . Dr.

He earned his master's degree in biotechnology from Jawaharlal Nehru University in India and it was during

Ralf Jockers Ralf Jockers studied in Cologne and received a Ph.D. in biotechnology and biochemistry from

Prior to these roles this he was Head of Pharmacology at Heptares Therapeutics Ltd., a UK-based biotechnology

based in South Korea, has recently been named President of GPCR Therapeutics, USA, a newly incorporated Biotechnology

Her work is currently funded by Biotechnology and Biological Sciences Research Council (BBSRC), Diabetes

Trained initially as a biotechnology engineer, Jens discovered his true calling during an internship

She received her undergraduate degree in Biotechnology from KIIT University in India.

Elodie Dupuis earned her Master’s degree in biology and biotechnology engineering from the University Mathis holds a biotechnology engineering degree from the National School of Biomolecule Technology of

competitive, charitable and commercial sources, as well as being academic co-founder of three GPCR-focussed biotechnology

competitive, charitable and commercial sources, as well as being academic co-founder of three GPCR-focussed biotechnology

competitive, charitable and commercial sources, as well as being academic co-founder of three GPCR-focussed biotechnology

networking, mentorship, PhD resilience, COVID-19 challenges, and his aspiration to transition into biotechnology

Welcome to Flash News—your fastest track to the latest updates in GPCR research, pharmacology, and biotechnology